Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
about
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An UpdateThe role of biomarkers and imaging in Parkinson's disease.Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Neuromelanin in parkinsonian disorders: an update.Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.Magnetic resonance imaging for the diagnosis of Parkinson's disease.In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.Parkinson's disease and atypical parkinsonism: the importance of magnetic resonance imaging as a potential biomarker.Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.The Aging of Iron Man.Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism
P2860
Q28076062-109DCC79-CC7F-4804-9C2D-97BDDA567222Q31041660-E8304071-4C4E-4C87-AF4B-07E8797AC788Q33831798-38E4C599-42C8-4EF8-B5DE-810460C596F7Q36359956-ED85F2DE-B192-4E90-B10B-6E838CAE5923Q39119095-E5D1D805-4187-4F00-AA2A-A15668395D0EQ39220904-61FCCD0F-64CA-43D7-956A-AD8D85AF711EQ39758264-73197952-FD85-42FD-8B6C-BBFFBE7C8129Q39877122-60C3A5BD-366F-400A-92D1-BBD6EDAB64D8Q46155272-6A768A17-57DF-4BC8-9C6C-DC48040FF1F2Q47183452-AA3B0E6B-278B-4282-A52E-754178E1A77EQ47674599-31C76BCD-7AE3-44D6-8CDE-A525D7D01847Q47680043-7609601D-6E60-44BA-8AA4-FFA2DF59A10CQ50145224-13E5C052-F500-4BCC-AB21-027752CC272CQ50243985-683F23AB-21B7-4A86-8B2F-885231F577D1Q51758684-F8803FCD-E1A6-4DCA-8B5E-E6319933CA86Q58576300-E0D1873B-95BB-41EF-AD49-5D394D73591E
P2860
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@en
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@nl
type
label
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@en
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@nl
altLabel
Substantia nigra neuromelanin ...... voParkinson's disease patients
@en
prefLabel
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@en
Substantia nigra neuromelanin ...... Parkinson's disease patients.
@nl
P2093
P2860
P356
P1476
Substantia nigra neuromelanin ...... o Parkinson's disease patients
@en
P2093
J Ferreira
J J Ferreira
L Correia Guedes
N Gonçalves
P Pita Lobo
P2860
P304
P356
10.1111/ENE.12613
P577
2014-12-22T00:00:00Z